Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Viktor Jankó"'
Autor:
Jan Lebl, Jitka Kytnarova, Tomáš Dallos, Ľudmila Košťálová, Gabriela Hrčková, Jiří Zeman, Daniela Virgová, Michaela Čižmárová, L. Kovács, Markéta Tesařová, Viktor Jankó, Vaclav Hana
Publikováno v:
European Journal of Pediatrics. 175:1199-1207
Familial neurohypophyseal diabetes insipidus (FNDI) is a rare hereditary disorder with unknown prevalence characterized by arginine-vasopressin hormone (AVP) deficiency resulting in polyuria and polydipsia from early childhood. We report the clinical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b88bc63fe260859c14b30f2245732b43
https://doi.org/10.1007/s00431-016-2759-x
https://doi.org/10.1007/s00431-016-2759-x
Autor:
Marta Kmeťová, L. Siegfried, Jan Luha, László Kovács, Viktor Jankó, Ján Koreň, Katarína Čurová, Helena Hupkova
Publikováno v:
Folia Microbiologica. 58:53-59
A total of 145 Escherichia coli strains causing pyelonephritis in children were investigated for the prevalence of genes encoding the following virulence factors (VFs): P fimbria (67.6 %), S fimbria (53.8 %), AFA adhesins (2.8 %), cytotoxic necrotizi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9621d44f0b468b945b44d0ce472e06ee
https://doi.org/10.1007/s12223-012-0176-8
https://doi.org/10.1007/s12223-012-0176-8
Publikováno v:
Journal of the American Society of Hypertension : JASH. 6(5)
The goal of our study was to analyze the association between obesity and the severity of ambulatory hypertension in obese children. A total of 109 patients with primary obesity ages 7 to 18 years (mean ± SD age 14.1 ± 3.1) were enrolled. Patients w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::411809aefb4a146df211ba5b15e026c0
https://pubmed.ncbi.nlm.nih.gov/22995804
https://pubmed.ncbi.nlm.nih.gov/22995804
Autor:
Nóra Garam, Marcell Cserhalmi, Zoltán Prohászka, Ágnes Szilágyi, Nóra Veszeli, Edina Szabó, Barbara Uzonyi, Attila Iliás, Christof Aigner, Alice Schmidt, Martina Gaggl, Gere Sunder-Plassmann, Dóra Bajcsi, Jürgen Brunner, Alexandra Dumfarth, Daniel Cejka, Stefan Flaschberger, Hana Flögelova, Ágnes Haris, Ágnes Hartmann, Andreas Heilos, Thomas Mueller, Krisztina Rusai, Klaus Arbeiter, Johannes Hofer, Dániel Jakab, Mária Sinkó, Erika Szigeti, Csaba Bereczki, Viktor Janko, Kata Kelen, György S. Reusz, Attila J. Szabó, Nóra Klenk, Krisztina Kóbor, Nika Kojc, Maarten Knechtelsdorfer, Mario Laganovic, Adrian Catalin Lungu, Anamarija Meglic, Rina Rus, Tanja Kersnik Levart, Ernesta Macioniene, Marius Miglinas, Anna Pawłowska, Tomasz Stompór, Ludmila Podracka, Michael Rudnicki, Gert Mayer, Romana Rysava, Jana Reiterova, Marijan Saraga, Tomáš Seeman, Jakub Zieg, Eva Sládková, Natasa Stajic, Tamás Szabó, Andrei Capitanescu, Simona Stancu, Miroslav Tisljar, Kresimir Galesic, András Tislér, Inga Vainumäe, Martin Windpessl, Tomas Zaoral, Galia Zlatanova, Mihály Józsi, Dorottya Csuka
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
BackgroundFactor H-related protein 5 (FHR-5) is a member of the complement Factor H protein family. Due to the homology to Factor H, the main complement regulator of the alternative pathway, it may also be implicated in the pathomechanism of kidney d
Externí odkaz:
https://doaj.org/article/0c908e2545e94fcd87521ab9c91fb160
Autor:
Nóra Garam, Zoltán Prohászka, Ágnes Szilágyi, Christof Aigner, Alice Schmidt, Martina Gaggl, Gere Sunder-Plassmann, Dóra Bajcsi, Jürgen Brunner, Alexandra Dumfarth, Daniel Cejka, Stefan Flaschberger, Hana Flögelova, Ágnes Haris, Ágnes Hartmann, Andreas Heilos, Thomas Mueller, Krisztina Rusai, Klaus Arbeiter, Johannes Hofer, Dániel Jakab, Mária Sinkó, Erika Szigeti, Csaba Bereczki, Viktor Janko, Kata Kelen, György S. Reusz, Attila J. Szabó, Nóra Klenk, Krisztina Kóbor, Nika Kojc, Maarten Knechtelsdorfer, Mario Laganovic, Adrian Catalin Lungu, Anamarija Meglic, Rina Rus, Tanja Kersnik-Levart, Ernesta Macioniene, Marius Miglinas, Anna Pawłowska, Tomasz Stompór, Ludmila Podracka, Michael Rudnicki, Gert Mayer, Romana Rysava, Jana Reiterova, Marijan Saraga, Tomáš Seeman, Jakub Zieg, Eva Sládková, Tamás Szabó, Andrei Capitanescu, Simona Stancu, Miroslav Tisljar, Kresimir Galesic, András Tislér, Inga Vainumäe, Martin Windpessl, Tomas Zaoral, Galia Zlatanova, Dorottya Csuka
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 14, Iss 1, Pp 1-14 (2019)
Abstract Background Acquired or genetic abnormalities of the complement alternative pathway are the primary cause of C3glomerulopathy(C3G) but may occur in immune-complex-mediated membranoproliferative glomerulonephritis (IC-MPGN) as well. Less is kn
Externí odkaz:
https://doaj.org/article/69c3689758b34c40a3dddf8458dfe664